Clinical evaluation for the efficacy of Muliv strong syrup in the management of Non- Alcoholic Fatty Liver disease (NAFLD).
- Conditions
- Other specified inflammatory liverdiseases,
- Registration Number
- CTRI/2019/12/022578
- Lead Sponsor
- Multani Pharmaceuticals Ltd
- Brief Summary
It is an open labeled single armed, single centric, prospective interventional clinical study to evaluate the efficacy of Muliv Strong Syrup on 50 patients suffering Non- Alcoholic Fatty Liver disease (NAFLD). The study will be conducted in National Institute of Ayurveda, Jaipur, Rajasthan,
Dose: 10 ml tds Muliv Strong Syrup orally will be given before meal with luke warm water for 45days.
**Purpose** –
To evaluate the effect of Muliv Strong Syrup in the management of Non- Alcoholic Steatohepatitis (NASH).
**Research question:** Is Muliv Strong Syrup is effective in management of Non- Alcoholic Fatty Liver disease (NAFLD).
**Null Hypothesis**: Muliv Strong Syrup is not effective in the management of Non- Alcoholic Fatty Liver disease (NAFLD).
**Alternative hypothesis**: Muliv Strong Syrup is effective in the management of Non- Alcoholic Fatty Liver disease (NAFLD).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- All
- Target Recruitment
- 50
- Patients of either sex not taking any medicine will be included in the study.
- Individuals suffering from NAFLD with or without elevated liver enzymes or hepatomegaly will be included.
- Patients willing to give informed consent for the study.
- Individuals with chronic hepatitis (more than 3 months), Patients with malignant jaundice, patient with acute hepatitis (Other than infective).
- Individuals with known hypersensitivity to ingredients of study products; individuals with immediate life threatening diseases such as preexisting cardiovascular, liver, or neoplastic diseases or who received any immunosuppressant, sedative, hypnotic or tranquilizer within 14 days prior to enrollment; 3.
- Individuals with any psychiatric illness which may impair the ability to provide written ICF.
- Individuals participating in any other clinical trial.
- Pregnant or lactating females.
- Alcohol, smoke, and drug abusers will be excluded from study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in NAFLD Score 60 days
- Secondary Outcome Measures
Name Time Method Changes in Subjective parameters, LFT, USG 60days
Trial Locations
- Locations (1)
National Institute of Ayurveda
🇮🇳Jaipur, RAJASTHAN, India
National Institute of Ayurveda🇮🇳Jaipur, RAJASTHAN, IndiaDr Gopesh MangalPrincipal investigator8619849011gmangal108@gmail.com